Discover proposed reforms to expedite drug approvals in Medicare and Medicaid. Learn how new electronic systems could streamline healthcare access.

Novo Nordisk applies for FDA approval of oral anti-obesity drug following Eli Lilly's clinical success, intensifying competition in the GLP-1 diabetes and weight loss market.